The Surgical Management of Head and Neck Sarcoma: The Newcastle Experience

Abstract Introduction Sarcomas occurring in the head and neck are rare and difficult to manage surgically. Factors which influence prognosis include; type and grade of tumour, resection margins, anatomical site and patient specific factors. We review our experience of managing these tumours surgical...

Full description

Saved in:
Bibliographic Details
Published inJournal of plastic, reconstructive & aesthetic surgery Vol. 70; no. 1; pp. 78 - 84
Main Authors Breakey, R.W.F, Anderson, I.B, Crowley, T.P., Mr, Milner, R.H, Ragbir, M
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Introduction Sarcomas occurring in the head and neck are rare and difficult to manage surgically. Factors which influence prognosis include; type and grade of tumour, resection margins, anatomical site and patient specific factors. We review our experience of managing these tumours surgically as plastic surgeons within a bone and soft tissue tumour multi disciplinary team. Methods Data on all patients with sarcoma of the head or neck managed surgically from 2004-2014 was reviewed. Demographics, surgical details and outcomes were analysed. Results Forty-nine patients underwent surgery for sarcoma of the head or neck. The mean age at presentation was 53.1 years (range 0.5-92). Histological diagnosis was varied. Leiomyosarcoma (n=6), angiosarcoma (n=9), synovial sarcoma (n=4), sarcoma of no specific type (n=5) and rhabdomyosarcoma (n=5) were the most frequently seen tumours. All were treated by wide excision. Excision margins were histologically complete in the vast majority (n=43). Reconstruction was undertaken as follows: direct closure (n=12), local flap +- skin graft (n=12), free tissue transfer (n=21), pedicled flap +- skin graft (n=3), skin graft (n=1). Twelve patients received adjuvant chemotherapy and fifteen patients received adjuvant radiotherapy. Eleven patients developed local recurrence and ten patients developed metastasis. Twelve patients died of their disease; mean survival 17 months (range 8-28). The mean duration of follow up was 78 months (range 18-137 months). Estimated 5-year disease specific survival for this cohort was 72% and overall estimated survival was 61% (Kaplan-Meier equation). Conclusion Head and neck sarcomas are rare and challenging to manage. Successful outcomes can be achieved by early, aggressive resection and appropriate reconstruction within the specialist MDT setting.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1748-6815
1878-0539
DOI:10.1016/j.bjps.2016.09.026